# Vaccine and Treatment Evaluation Units: Clinical Operations Support

> **NIH NIH N01** · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · 2021 · $150,303

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

## Key facts

- **NIH application ID:** 10490801
- **Project number:** 272201300019I-P00002-759301900131-1
- **Recipient organization:** KAISER FOUNDATION HEALTH PLAN OF WASHINGTON
- **Principal Investigator:** LISA JACKSON
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $150,303
- **Award type:** —
- **Project period:** 2019-07-12 → 2022-07-12

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10490801

## Citation

> US National Institutes of Health, RePORTER application 10490801, Vaccine and Treatment Evaluation Units: Clinical Operations Support (272201300019I-P00002-759301900131-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10490801. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*